Supporting Equity in Value Assessment

Author: Rick Chapman, PhD, Chief Science Officer, IVI How do we ensure that the data and methods used for value assessment adequately account for the diversity of patients and the urgent need to correct inequities in the health care system – and society in general? Without explicit attention to these issues, health technology assessment [...]

2021-08-25T11:24:08-04:00August 25th, 2021|Blog|

What Distinguishes IVI’s Approach to Value Assessment?

Author: Rick Chapman, PhD, Chief Science Officer, IVI Policymakers continue to grapple with finding the right approaches to curtailing drug costs and improving health care. Organizations that conduct value and health technology assessment (HTA) are grappling with finding the right approaches, too. IVI has created a new infographic to illustrate our patient-centered approach to [...]

2021-08-20T09:21:01-04:00August 16th, 2021|Blog|
Go to Top